Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,445 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mid (6.8bn) 1–5 $100M+ 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No activity — —
Pharmaceuticals & Medical Research Mid (6.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.6bn) 0 No activity — 0–15%
Healthcare Services Mid (6.5bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.3bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US RadNet Inc (RDNT)
Healthcare Services Mid (6.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.1bn) 0 No activity — 15–50%
Healthcare Services Mid (6.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (6.0bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.9bn) 0 No activity — 15–50%
Healthcare Services Mid (5.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.7bn) -1–5 -$1M–$10M -0–15% 0–15%
SE Sectra AB (SECT-B)
Healthcare Services Mid (5.6bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (5.6bn) -1–5 -$10M–$100M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (5.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 No activity — 0–15%
Healthcare Services Mid (5.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (5.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.4bn) 0 No activity — 0–15%
Healthcare Services Mid (5.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.4bn) 0 No activity — 15–50%
CH Galenica AG (GALE)
Pharmaceuticals & Medical Research Mid (5.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 No activity — 0–15%
Healthcare Services Mid (5.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.2bn) 0 No activity — 15–50%
US Grail Inc (GRAL)
Pharmaceuticals & Medical Research Mid (5.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.2bn) 0 No activity — 0–15%
Healthcare Services Mid (5.1bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.1bn) 1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) -1–5 -$100K–$1M -0–15% 0–15%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals & Medical Research Mid (4.8bn) 0 No activity — 50%+
Healthcare Services Mid (4.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (4.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) -1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Healthcare Services Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Healthcare Services Mid (4.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Healthcare Services Mid (4.4bn) 0 No activity — 50%+
Healthcare Services Mid (4.4bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Mid (4.4bn) -1–5 -$100K–$1M -0–15% 0–15%
SE Medicover AB (MCOV-B)
Healthcare Services Mid (4.4bn) 0 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (4.3bn) -1–5 -$1M–$10M -0–15% 0–15%
SE Camurus AB (CAMX)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (4.3bn) 1–5 < $100K 0–15% 0–15%
IN Biocon Ltd (BIOCON)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (4.3bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (4.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
US TESARO Inc (TSRO)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — —
US Metsera Inc (MTSR)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Healthcare Services Mid (4.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (4.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 1–5 $1M–$10M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No activity — 0–15%
Healthcare Services Mid (3.8bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 $1M–$10M 0–15% 15–50%
Healthcare Services Mid (3.8bn) 0 No activity — 0–15%
Healthcare Services Mid (3.8bn) 1–5 $100K–$1M 0–15% 50%+
US Perrigo Co (PRGO)
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No activity — 0–15%
Healthcare Services Mid (3.7bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.6bn) 0 No activity — 0–15%
Healthcare Services Mid (3.6bn) 0 No activity — 0–15%
Loading...